Authors


Cynthia L. Bero, MPH

Latest:

Achieving Meaningful Use: A Health System Perspective

The experience of Partners HealthCare offers some unique insights into the process of electronic medical record adoption across a large, diverse health system.


Steven B. Shoemaker, MD

Latest:

High clopidogrel maintenance dosage in patients with diabetes mellitus and coronary artery disease

Patients with type 2 diabetes mellitus have decreased platelet inhibition and decreased responsiveness to standard doses of clopidogrel compared with patients without diabetes. In this pilot study, we showed that increasing the maintenance dose of clopidogrel to 150 mg leads to enhanced platelet inhibition compared with the standard dose of 75 mg in patients with type 2 diabetes with suboptimal responsiveness. The clinical implications of these findings are unknown, however, and need to be evaluated in large-scale clinical trials.


Michael D. Becker

Latest:

Tech Sectors: Biotechnology: The Treatment of Palmar-plantar Erythrodysesthesia

A potential new candidate uses uracil to combat this cancer treatment side effect.


Amanda Bernier, MD, Frank J. Domino, MD

Latest:

Antiviral Treatment vs. Herpes Zoster Vaccines for Postherpetic Neuralgia

This review and meta-analysis assessed whether antiviral treatment given during the acute herpes zoster rash is effective at preventing postherpetic neuralgia in patients with a first-time case of shingles.


Luther T. Clark, MD is chief, Division of Cardiovascular Medicine, State University of New York Downstate Medical Center, Brooklyn, New York.

Latest:

The safety of long-term low cholesterol levels

In their study, Strandberg and Strandberg (page 13) found that during a 39-year follow-up of initially healthy men, aged 30 to 45 years (mean, 38 years), low serum cholesterol levels predicted better survival, better physical function, and better quality of life in old age, without adversely affecting mental functioning.



Peng Fan, MD

Latest:

Evaluating a Young Patient with Joint Pain and Stiffness Part 2

You see a 29-year-old female insurance saleswoman with a 6-week history of joint pains and swelling affecting both hands and wrists, both feet and her left knee. Her symptoms are worse when she first gets up in the morning and it takes a few hours before her joints seem to loosen up.



Jing Zhang MD, PhD2

Latest:

Iatrogenic dilated cardiomyopathy and spectrum of current treatment modalities

Our increasing ability to intervene in high-risk patients—with lower risks and greater chances for successful outcomes—is felt across the broad spectrum of cardiovascular disease. This is particularly evident in patients with dilated cardiomyopathy (DCM).




Edibaldo Silva, MD, PhD

Latest:

Back to the Future: Why Are More Women Having Bilateral Mastectomy for Unilateral Breast Cancer?

Since 2003, the rate of women choosing breast-conserving surgery for the management of early-stage breast cancer has declined, with an accompanying recidivism to mastectomy. Edibaldo Silva, MD, PhD, examines the reasons for the treatment regression.



Prachi Patel-Predd

Latest:

The Industry Insider: April 2007

Companies in the news: 1) AVAX and CTCA Collaborating for Cancer Therapies 2) Full Speed Ahead for GPC Biotech's Satraplatin 3) Bristol-Myers Squibb Company / Adnexus Therapeutics: Collaboration for New Oncology Compounds 4) Graffinity and Amgen in Drug Discovery Agreement 5) Roche Suspends Enrollment in CERA Phase II Oncology Trial


Kenneth Bender, PharmD, MA

Latest:

Multiple Genetic Variants Likely Underlie Early Onset Drusen Maculopathy

Whole genome sequencing suggests both common and rare variants contribute to early onset drusen maculopathy.



Brian G.M. Durie, MD, Robert J. Kreitman, MD

Latest:

ASH Interview Series

The December issue of Oncology & Biotech News featured highlights from the 51st American Society of Hematology (ASH) Annual Meeting and Exposition. We wrap up our ASH coverage this month with interviews on multiple myeloma with Brian G.M. Durie, MD, medical director and co-founder of the International Myeloma Foundation; chronic lymphocytic leukemia (CLL) with Robert J. Kreitman, MD, from the National Cancer Institute; and chronic myeloid leukemia (CML) with Francis J. Giles, MD, Cancer Therapy and Research Center at The University of Texas Health Science Center in San Antonio.


associate pro

Latest:

Never too old for statins

Elderly patients with a history of an acute coronary syndrome (ACS) are at higher risk for subsequent cardiovascular events than younger patients.


Timothy S. Harlan, MD (aka Dr. Gourmet)

Latest:

Can Red Meat be Part of a Healthy Diet?

Over the past four decades, red meat has gotten a bad rap. Consumption of beef, pork, and lamb has been linked with poor cholesterol scores and increased risk of breast, colon, and rectal cancers as well as diabetes and a host of other chronic diseases. The conventional wisdom has, however, lumped all red meats into a single group and arrived at a blanket judgment that eating any red meat is equally harmful.




John R. Hoyle, MD: From the Department of Cardiology,Wake Forest University Bapti

Latest:

Contemporary cardiac imaging in hypertrophic obstructive cardiomyopathy

Features of hypertrophic obstructive cardiomyopathy (HOCM) include obstruction at the left ventricular outflow tract (caused by a markedly thickened proximal interventricular septum) and systolic anterior motion of the mitral valve. The case discussed here illustrates several classic features of this disease including clinical presentation, diagnostic workup, and noninvasive and invasive management.


Marc L. Baker, MD, PhD

Latest:

A Classic Case of Mitral Valve Endocarditis

A young woman presented with fevers, chills and a holosystolic murmur that radiated to her axilla, and became louder with handgrip maneuvers.




Charité Berlin, Department of Medicine, Outpatient Clinic, Berlin, Germany.

Latest:

Obesity-related hypertension

To evaluate the interactions between the weight loss drug, sibutramine, and different antihypertensive treatments, we randomly assigned 171 subjects taking 3 antihypertensive treatment regimens to receive sibutramine or placebo. Our study showed for the first time that combination therapy with an angiotensin-converting enzyme inhibitor and a calcium channel blocker is more advantageous than a ß blocker/diuretic-based-regimen with regard to supporting the weight-reducing actions and metabolic changes induced by sibutramine.



Henry Wei, MD

Latest:

Why Online Social Networking Should Change What We Know about Health Care

Rather than being a force for depersonalizing medicine and driving a wedge between patients and physicians, it turns out that information technology and social media offer new opportunities for deeper communication and interaction.



John Harelson

Latest:

Ten Questions to Ask Yourself before Choosing a New Bank

Use the negative financial climate to your advantage when choosing a new banking partner. These ten questions will help you determine whether the banks on your short list can handle your needs.

© 2024 MJH Life Sciences

All rights reserved.